Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Deficit (Unaudited)

v3.19.3
Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)
Common Stock
Preferred Stock
Series A Convertible Preferred stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
to be Issued
Additional Paid-in Capital
Retained Earnings
Total
Equity Balance, Starting at Dec. 31, 2017 $ 5,457 $ 0 $ 0 $ 50 $ 50 $ 24,000 $ 15,923,789 $ (22,237,839) $ (6,284,493)
Shares Outstanding, Starting at Dec. 31, 2017 54,564,441 0 0 500,000 500,000        
Common stock issued against Common stock to be issued $ 0 $ 0 $ 0 $ 0 $ 0 (15,000) 15,000 0 0
Stock Issued During Period, Shares, New Issues 2,179 0 0 0 0        
Common shares issued in redemption of note, value $ 193 $ 0 $ 0 $ 0 $ 0 0 403,289 0 403,482
Common shares issued in redemption of note, shares 1,925,830 0 0 0 0        
Common stock issued for consulting services $ 17 $ 0 $ 0 $ 0 $ 0 0 817,783 0 817,800
Common stock issued for consulting services, shares 174,000 0 0 0 0        
Common stock to be issued for consulting services $ 0 $ 0 $ 0 $ 0 $ 0 9,500 0 0 9,500
Common stock to be issued for consulting services, shares 0 0 0 0 0        
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (2,763,492) (2,763,492)
Shares Outstanding, Ending at Mar. 31, 2018 56,666,450 0 0 500,000 500,000        
Equity Balance, Ending at Mar. 31, 2018 $ 5,667 $ 0 $ 0 $ 50 $ 50 18,500 17,159,861 (25,001,331) (7,817,203)
Common stock to be issued for consulting services $ 0 $ 0 $ 0 $ 0 $ 0 18,820 0 0 18,820
Common stock to be issued for consulting services, shares 0 0 0 0 0        
Common stock to be issued to Board of directors $ 0 $ 0 $ 0 $ 0 $ 0 125,000 0 0 125,000
Stock Issued During Period, Value, Other $ 67 0 0 0 0 0 1,784,465 0 1,784,532
Stock Issued During Period, Shares, Other 670,000                
Common stock issued per stock purchase agreement $ 21 $ 0 $ 0 $ 0 $ 0 0 599,979 0 600,000
Common stock issued per stock purchase agreement, shares 204,778 0 0 0 0        
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (1,678,566) (1,678,566)
Shares Outstanding, Ending at Jun. 30, 2018 57,541,228 0 0 500,000 500,000        
Equity Balance, Ending at Jun. 30, 2018 $ 5,755 $ 0 $ 0 $ 50 $ 50 4,162,320 19,544,305 (26,679,897) (6,967,417)
Common shares issued in redemption of note, value $ 23 $ 0 $ 0 $ 0 $ 0 0 514,485 0 514,508
Common shares issued in redemption of note, shares 231,215 0 0 0 0        
Common stock to be issued for consulting services $ 1 $ 0 $ 0 $ 0 $ 0 0 36,539 0 36,540
Common stock to be issued for consulting services, shares 18,000 0 0 0 0        
Stock Issued During Period, Value, Other $ 88 $ 0 $ 0 $ 0 $ 0 0 1,551,112 0 1,551,200
Stock Issued During Period, Shares, Other 875,000 0 0 0 0        
Reversal of Common shares issued for consulting services, value $ 0 $ 0 $ 0 $ 0 $ 0 (3,820) 0 0 (3,820)
Reversal of Common shares issued for consulting services, shares 0 0 0 0 0        
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (1,333,696) (1,333,696)
Shares Outstanding, Ending at Sep. 30, 2018 58,665,443 0 0 500,000 500,000        
Equity Balance, Ending at Sep. 30, 2018 $ 5,867 $ 0 $ 0 $ 50 $ 50 158,500 21,646,441 (28,013,593) (6,202,685)
Equity Balance, Starting at Dec. 31, 2018 $ 5,958 $ 0 $ 0 $ 50 $ 50 41,000 22,863,608 (28,992,485) (6,081,819)
Shares Outstanding, Starting at Dec. 31, 2018 59,582,890 0 0 500,000 500,000        
Common stock issued against Common stock to be issued $ 0 $ 0 $ 0 $ 0 $ 0 7,500 0 0 7,500
Stock Issued During Period, Shares, New Issues 0 0 0 0 0        
Stock Issued During Period, Value, Other $ 125 $ 0 $ 0 $ 0 $ 0 0 1,592,687 0 1,592,812
Stock Issued During Period, Shares, Other 1,250,000 0 0 0 0        
Common stock issued per stock purchase agreement $ 24 $ 0 $ 0 $ 0 $ 0 0 399,976 0 400,000
Common stock issued per stock purchase agreement, shares 239,521 0 0 0 0        
Stock based compensation - stock options $ 0 $ 0 $ 0 $ 0 $ 0 0 1,137,500 0 1,137,500
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (2,342,677) (2,342,677)
Shares Outstanding, Ending at Mar. 31, 2019 61,072,411 0 0 500,000 500,000        
Equity Balance, Ending at Mar. 31, 2019 $ 6,107 $ 0 $ 0 $ 50 $ 50 48,500 25,993,771 (31,335,162) (5,286,684)
Equity Balance, Starting at Dec. 31, 2018 $ 5,958 $ 0 $ 0 $ 50 $ 50 41,000 22,863,608 (28,992,485) (6,081,819)
Shares Outstanding, Starting at Dec. 31, 2018 59,582,890 0 0 500,000 500,000        
Gain on settlement of liabilities transferred to capital $ 0 $ 0 $ 0 $ 0 $ 0   0 0 0
Shares Outstanding, Ending at Sep. 30, 2019 62,785,419 0 0 500,000 500,000        
Equity Balance, Ending at Sep. 30, 2019 $ 6,279 $ 0 $ 0 $ 50 $ 50 7,500 27,812,413 (34,003,930) (6,177,638)
Equity Balance, Starting at Mar. 31, 2019 $ 6,107 $ 0 $ 0 $ 50 $ 50 48,500 25,993,771 (31,335,162) (5,286,684)
Shares Outstanding, Starting at Mar. 31, 2019 61,072,411 0 0 500,000 500,000        
Common stock issued against Common stock to be issued $ 2 $ 0 $ 0 $ 0 $ 0 (48,500) 48,498 0 0
Stock Issued During Period, Shares, New Issues 19,668 0 0 0 0        
Common stock to be issued for consulting services $ 0 $ 0 $ 0 $ 0 $ 0 7,500 0 0 7,500
Common stock to be issued for consulting services, shares 0 0 0 0 0        
Stock Issued During Period, Value, Other $ 75 $ 0 $ 0 $ 0 $ 0 0 695,926 0 696,001
Stock Issued During Period, Shares, Other 750,000 0 0 0 0        
Fair value of stock options $ 0 $ 0 $ 0 $ 0 $ 0 0 227,500 0 227,500
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (1,805,150) (1,805,150)
Shares Outstanding, Ending at Jun. 30, 2019 61,842,079 0 0 500,000 500,000        
Equity Balance, Ending at Jun. 30, 2019 $ 6,184 $ 0 $ 0 $ 50 $ 50 7,500 26,965,695 (33,140,312) (6,160,833)
Common stock issued against Common stock to be issued $ 1 $ 0 $ 0 $ 0 $ 0 (7,500) 7,499 0 0
Stock Issued During Period, Shares, New Issues 6,055 0 0 0 0        
Common stock to be issued for consulting services $ 0 $ 0 $ 0 $ 0 $ 0 7,500 0 0 7,500
Common stock to be issued for consulting services, shares 0 0 0 0 0        
Stock Issued During Period, Value, Other $ 25 $ 0 $ 0 $ 0 $ 0 0 111,788 0 111,813
Stock Issued During Period, Shares, Other 250,000 0 0 0 0        
Common stock issued per stock purchase agreement $ 69 $ 0 $ 0 $ 0 $ 0 0 499,931 0 500,000
Common stock issued per stock purchase agreement, shares 687,285 0 0 0 0        
Stock Issued During Period, Value, Stock Options Exercised $ 0 $ 0 $ 0 $ 0 $ 0 0 227,500 0 227,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0 0 0 0 0        
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 0 (863,618) (863,618)
Shares Outstanding, Ending at Sep. 30, 2019 62,785,419 0 0 500,000 500,000        
Equity Balance, Ending at Sep. 30, 2019 $ 6,279 $ 0 $ 0 $ 50 $ 50 $ 7,500 $ 27,812,413 $ (34,003,930) $ (6,177,638)